JD Supra9d
Transparency Is the Best Medicine: Device Parts Don’t Justify Orange Book Listing
The US Court of Appeals for the Federal Circuit affirmed a district court’s delisting of patents from the Orange Book because the patent claims ...
JD Supra16d
Teva v. Amneal Ruling Interprets Orange Book Listing Statute, Affirms Delisting of Device Patents
On December 20, 2024, the US Court of Appeals for the Federal Circuit released its opinion in Teva Branded Pharm. Prods. R&D, Inc. v. Amneal ...
USA Today27d
FDA approves generic in same class as Ozempic for diabetes. Could it ease shortage, price?
In a move that could eventually make weight loss drugs cheaper and easier to access, the Food and Drug Administration Monday approved a second generic in the category of medications known as GLP-1s.